Close Menu

University of Texas Health Science Center

In PNAS this week: blood plasma lipidome analysis of Ebola patients, genome organization of the malaria-causing parasite, and more.

Investigators analyzed the inactivation of tumor suppressor genes and its transcriptional consequences in thousands of tumors from 33 cancer types or subtypes.

Using data for almost 10,900 Latino individuals with diverse ancestry, investigators identified distinct patterns for risky or protective APOE variants.

The goal of the Texas team is to identify methylation signatures that can help with prognosis and be used to develop noninvasive tests to monitor disease progression.

NEW YORK (GenomeWeb) – Two new Nature studies by independent research groups catalogued and characterized the role that rare, protein-coding mutations or variants play in autism spectrum disorder.

Researchers from Rice University, the University of Texas MD Anderson Cancer Center, Baylor College of Medicine, and the University of Texas Health Science Center in San Antonio will program bio-nano-chips to find biomarkers for several forms of cancer, as well as HIV and heart disease.

The awards will support projects investigating the roles the small, non-coding RNAs play in cancer and asthma.

Genetic Alliance, UTHSC, and others will create a newborn screening data center and resource using a $3.8 million grant.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.